Stay updated on Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows the latest site revision as v3.5.3, replacing the prior v3.5.2, indicating a minor platform update.
    Difference
    0.1%
    Check dated 2026-04-30T15:38:57.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; no study content changes are evident on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:48:38.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:00:38.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T12:31:47.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T05:09:15.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding is now displayed on the page, with guidance about the NIH Clinical Center's status. The site revision has been updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T04:46:24.000Z thumbnail image

Stay in the know with updates to Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial page.